Over the last 40 years, Glenmark has built the resources and talent to work on solving serious medical problems, all the while doing the right thing for patients, people and communities.

Glenmark’s R&D is dedicated to addressing unmet medical needs in inflammatory disorders, especially in respiratory, dermatology and also oncology. Our focus on these therapy areas is based on their significant size, rapid rates of growth, and our cumulative experience and track record in brand-building and patient-focused innovation. We also see a vast unmet need across these therapy areas for better, more economical and more convenient therapies.